Join today and have your say! It’s FREE!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}

Join today with :


By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Sign in with existing account
Please Try Again
{{ error }}

Sign In With :


Password Hint : {{passwordHint}}
Forgot Password?
Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

FSD Partner Announces Positive Results for CBD Patent

Stockhouse Editorial
0 Comments| November 6, 2018

FSD Pharma Inc. (CSE: HUGEOTCQB: FSDDFForum) on Tuesday stated that its partner, SciCann Therapeutics Inc. received a positive International Search Authority report from the Patent Cooperation Treaty for its SCN-001 cannabidiol combination therapy patent, the basis of FSD’s “Steady Stomach” product. 

For more on this, click here.

FSD was in the news recently when it announced that it has signed a binding letter of intent to acquire Therapix Biosciences Ltd. (NASDAQ: TRPX), thus combining two businesses to advance research and development of advanced cannabinoid treatments. Therapix shareholders will receive $62.4 million (CAD) of FSD stock upon closing of the transaction, which represents around 130 million class B subordinate shares of FSD Pharma and nearly 10% of the Company.

FULL DISCLOSURE: FSD Pharma Inc. is a paid client of Stockhouse Publishing.

Interested in these industries and sectors?

Receive investor kits and email updates from Stockhouse and directly from these companies.

Metals & Mining

Interested in these industries and sectors?

You are already a member! Please enter your password to sign in.


No comments yet. Be first to comment!

Leave a Comment

You must be logged in to access this feature.


Get our FREE StockTalk Investor Guides by sector as they are released!

Stay on top of sector specific news, get industry leaders insights and our best content, delivered to your email.

You are already a member! Please enter your password to sign in.